Sorrento Investors Fight To Lead COVID-19 'Cure' Suit
Sorrento Therapeutics Inc. investors represented by Pomerantz, Kirby McInerney and Robbins Geller continue to fight for appointment as lead plaintiff in a proposed securities class action accusing the company of misleading...To view the full article, register now.
Already a subscriber? Click here to view full article